Evotec SE EVO
NASDAQ EVO
$1.67 +0.05 (+3.09%)
At close: Sep 17, 2026 · 4:00 PM EDT

Evotec SE (EVO) Cash from Investing Activities (2009 - 2026)

Evotec SE's (EVO) quarterly Cash from Investing Activities came in at -$14.6 million in Q1 2026, up 35.95% year-over-year from -$10.7 million in Q1 2025, and up 71.28% quarter-over-quarter from -$50.7 million in Q4 2025.

Analysis

Evotec SE (EVO) Cash from Investing Activities (2009 - 2026) Analysis & Trends

Evotec SE has disclosed Cash from Investing Activities across 9 years of filings, most recently posting -$14.6 million for Q1 2026.

  • In Q1 2026, Cash from Investing Activities rose 35.95% year-over-year to -$14.6 million; the TTM figure through Mar 2026 stood at -$98.6 million (down 47.54% YoY), while the FY2025 annual figure was $193.9 million, up 351.62% from the prior year.
  • Cash from Investing Activities came in at -$14.6 million for Q1 2026 at Evotec SE, up from -$50.7 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $208.1 million in Q3 2022 to a low of -$420.7 million in Q4 2022.
  • Average Cash from Investing Activities over 5 years is -$39.9 million, with a median of -$26.7 million recorded in 2025.
  • The largest YoY upside for Cash from Investing Activities was 250.99% in 2022 against a maximum downside of 191439.37% in 2022.
  • Over 5 years, Cash from Investing Activities stood at -$420.7 million in 2022, then jumped by 92.33% to -$32.3 million in 2023, then soared by 156.01% to $18.1 million in 2024, then tumbled by 380.36% to -$50.7 million in 2025, then surged by 71.28% to -$14.6 million in 2026.
  • Per Business Quant data, the three most recent Cash from Investing Activities figures were -$14.6 million in Q1 2026, -$50.7 million in Q4 2025, and -$8.5 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn -381.00 Mn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn -23.89 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn -108.34 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn 28.10 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn -7.00 Mn
6 Evotec SE 574.75 Mn 148.87 Mn - -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn 11.09 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn -55,000.00
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn -55,941.69
10 VivoSim Labs 1.37 Mn 1.37 Mn - -23,000.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -14.56 Mn
Dec 31, 2025 -50.69 Mn
Sep 30, 2025 -8.47 Mn
Jun 30, 2025 -24.84 Mn
Mar 31, 2025 -22.73 Mn
Dec 31, 2024 18.08 Mn
Sep 30, 2024 -28.46 Mn
Jun 30, 2024 -33.69 Mn
Mar 31, 2024 -33.58 Mn
Dec 31, 2023 -32.28 Mn
Jun 30, 2023 26.29 Mn
Mar 31, 2023 5.00 Mn
Dec 31, 2022 -420.71 Mn
Sep 30, 2022 208.13 Mn
Jun 30, 2022 -118.58 Mn
Mar 31, 2022 -107.44 Mn
Dec 31, 2021 -445.62 Mn
Sep 30, 2021 59.30 Mn
Jun 30, 2021 116.22 Mn
Mar 31, 2021 -56,094.80